STOCK TITAN

QIAGEN N.V. to release results for Q2 2023 and hold webcast

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
QIAGEN N.V. plans to release Q2 2023 results on August 8, followed by a conference call on August 9. Three options are available to join the call.
Positive
  • QIAGEN N.V. will release its Q2 2023 results, which could positively affect the stock price if the results exceed market expectations.
Negative
  • None.

Venlo, The Netherlands, July 24, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter 2023.

Press release date / time: Tuesday, August 8, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Wednesday, August 9, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. 

Three options for joining the conference call

1.Register for call back connection - Click here: Connect me
Service available 15 minutes before call start 

2. Dial-in by phone 
U.S.: +1 646 828 8193
UK: +44 (0)330 165 3655
GER: +49 (0)69 6610 2490
Conference ID: 4878029
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time. 

3. Access the audio webcast - Click here: Access Webcast

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1596354&tp_key=0acb730754

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to
Insight solutions that enable customers to gain valuable molecular insights from samples containing
the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from
blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for
analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable
insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN
provides solutions to more than 500,000 customers around the world in Molecular Diagnostics
(human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily
forensics). As of March 31, 2023, QIAGEN employed more than 6,200 people in over 35 locations
worldwideFurther information can be found at http://www.qiagen.com.

source: QIAGEN N.V. 
category: Financial


FAQ

When will QIAGEN N.V. release its Q2 2023 results?

QIAGEN N.V. plans to release its Q2 2023 results on August 8.

When is the conference call for QIAGEN N.V.'s Q2 2023 results?

The conference call for QIAGEN N.V.'s Q2 2023 results will be held on August 9.

How can I join the conference call?

There are three options to join the conference call: 1. Register for call back connection, 2. Dial-in by phone, or 3. Access the audio webcast.

What is the conference ID for the call?

The conference ID for the call is 4878029.

QIAGEN N.V.

NYSE:QGEN

QGEN Rankings

QGEN Latest News

QGEN Stock Data

9.42B
221.85M
2.24%
86.83%
1.76%
Diagnostics & Research
Healthcare
Link
United States of America
Venlo